Genpact (NYSE:G) SVP Sells $8,610,000.00 in Stock

Genpact Limited (NYSE:G – Get Free Report) SVP Piyush Mehta sold 200,000 shares of the company’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $43.05, for a total value of $8,610,000.00. Following the sale, the senior vice president owned 156,823 shares of the company’s stock, valued at approximately $6,751,230.15. The trade was a 56.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Genpact Price Performance

Shares of G traded up $0.54 during trading hours on Friday, hitting $43.67. 2,444,134 shares of the company were exchanged, compared to its average volume of 2,396,008. The company has a quick ratio of 2.00, a current ratio of 1.95 and a debt-to-equity ratio of 0.42. Genpact Limited has a fifty-two week low of $26.85 and a fifty-two week high of $48.64. The company has a market cap of $7.30 billion, a price-to-earnings ratio of 12.73, a P/E/G ratio of 1.16 and a beta of 0.53. The firm’s fifty day moving average is $36.96 and its 200 day moving average is $35.47.

Genpact (NYSE:G – Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The business services provider reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.03. Genpact had a return on equity of 23.02% and a net margin of 11.04%. During the same period in the prior year, the firm earned $0.97 earnings per share. The business’s revenue was up 7.3% compared to the same quarter last year. On average, equities analysts anticipate that Genpact Limited will post 3.66 earnings per share for the current fiscal year.

Genpact Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 23rd. Stockholders of record on Thursday, December 10th will be given a $0.1875 dividend. The ex-dividend date is Thursday, December 10th. This represents a $0.75 annualized dividend and a dividend yield of 1.7%. Genpact’s payout ratio is presently 21.87%.

More Genpact News

Here’s some of the latest news about G:

  • Positive Sentiment: Recent coverage highlighted a 30.3% jump in technology revenue, which could reinforce optimism about growth in Genpact’s technology-focused business. Genpact stock gains as technology revenue jumps 30.3 percent
  • Neutral Sentiment: Genpact’s new survey found that while 79% of enterprises have AI agents in production, only 15% have tied AI investment to profit-and-loss outcomes. This highlights a significant opportunity for Genpact’s operations expertise, but also shows that converting AI adoption into measurable business value remains a challenge. Genpact report on AI agents and business value
  • Negative Sentiment: Senior Vice President Piyush Mehta sold 200,000 shares for about $8.61 million, cutting his direct holdings by 56.05%. The large insider sale could raise concerns, although it does not by itself indicate a change in the company’s outlook. SEC filing for Piyush Mehta share sale

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. BMO Capital Markets reiterated a “market perform” rating and set a $40.00 price target on shares of Genpact in a research report on Friday, August 7th. Weiss Ratings upgraded shares of Genpact from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, October 14th. Citigroup upped their target price on Genpact from $36.00 to $44.00 and gave the stock a “neutral” rating in a research note on Monday. Needham & Company LLC raised their target price on Genpact from $45.00 to $55.00 and gave the company a “buy” rating in a report on Friday, November 6th. Finally, Susquehanna lifted their price target on Genpact from $40.00 to $42.00 and gave the company a “neutral” rating in a research note on Friday, November 6th. Two investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, Genpact currently has an average rating of “Hold” and a consensus target price of $41.89.

Get Our Latest Report on G

Institutional Investors Weigh In On Genpact

A number of hedge funds have recently made changes to their positions in the stock. Fifth Third Bancorp boosted its stake in Genpact by 8.8% during the 1st quarter. Fifth Third Bancorp now owns 3,691 shares of the business services provider’s stock valued at $137,000 after purchasing an additional 300 shares during the last quarter. Allworth Financial LP raised its position in Genpact by 8.5% in the 3rd quarter. Allworth Financial LP now owns 4,078 shares of the business services provider’s stock worth $133,000 after buying an additional 321 shares during the last quarter. Basecamp Wealth Advisors LLC raised its position in Genpact by 54.7% in the 1st quarter. Basecamp Wealth Advisors LLC now owns 1,046 shares of the business services provider’s stock worth $39,000 after buying an additional 370 shares during the last quarter. Walled Lake Planning & Wealth Management LLC lifted its stake in Genpact by 0.4% during the 3rd quarter. Walled Lake Planning & Wealth Management LLC now owns 103,891 shares of the business services provider’s stock valued at $3,380,000 after acquiring an additional 406 shares during the period. Finally, Flynn Zito Capital Management LLC lifted its stake in Genpact by 4.8% during the 3rd quarter. Flynn Zito Capital Management LLC now owns 8,910 shares of the business services provider’s stock valued at $290,000 after acquiring an additional 408 shares during the period. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Genpact Company Profile

(Get Free Report)

Genpact is a global professional services company that helps businesses improve operations and pursue digital transformation. Its services include business process management, consulting, data and analytics, artificial intelligence, and technology implementation. The company works with clients across industries such as banking and financial services, insurance, consumer goods, healthcare, life sciences, manufacturing, and technology. It serves organizations around the world through its global operations.

Featured Articles

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.